Tag: Motley Fool

The PointsBet Holdings Ltd (ASX: PBH) share price has been suffering lately despite only good news being released by the company. Over the last 30 days, the stock’s value has fallen 16.5%.

At the time of writing, the PointsBet share price is $7.35, 2.78% lower than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) has gained 0.12% today but has fallen 1.12% over the last 30 days.

Let’s take a look at what the market has heard from the bookmaker lately.

What’s weighing on the PointsBet share price?

Interestingly, the PointsBet share price has continued to tumble over the last 30 days despite the only price-sensitive news from the company appearing to be positive.

On 24 November, the company announced it had been awarded a temporary sports betting supply licence in Virginia.

The news heralded the company’s first lottery-regulated market licence award. It will see PointsBet’s Virginian subsidiary offering online sports wagering in the state.

The company has previously partnered with NBC Sports to provide sports betting. It now plans to use the media giant’s television and digital assets to promote its own brand in Virginia.

Despite the apparent good news, the PointsBet share price fell 0.4% that day.

The dip could be a continued reaction to the bookmaker’s latest quarterly trading update, which saw its share price drop 18.2%.

As my Foolish colleague Mitchell reported at the time, the company’s growth was strong over the first quarter of financial year 2022.

Its turnover increased 42% on that of the prior comparative period. Additionally, the number of people who had placed a bet in the last 12 months increased 79% on that of the first quarter of financial year 2021.

However, its sales and marketing costs were substantial, potentially spurring the company’s share price’s fall.

Unfortunately, it continued to fall beyond the release of the update. The company’s stock hit a new 52-week low of $6.63 in early December.

Right now, the PointsBet share price is 35% lower than it was at the start of 2021.

The post Why has the PointsBet (ASX:PBH) share price tumbled 16.5% in a month? appeared first on The Motley Fool Australia.

More reading

• These were the best performing ASX 200 shares last week
• Goldman Sachs loves these ASX tech shares
• 10 ASX shares to buy in 2022
• Goldman sees “significant upside opportunity” for the PointsBet (ASX:PBH) share price
• Why the PointsBet (ASX:PBH) share price is racing higher today

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Pointsbet Holdings Ltd. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3DQZtYg

The high-performing fund manager Wilson Asset Management (WAM) has recently identified some ASX blue-chip shares that it owns (or owned) in one of its leading portfolios.

WAM operates several listed investment companies (LICs). Two of those LICs are WAM Capital Limited (ASX: WAM) and WAM Research Limited (ASX: WAX).

There’s also one called WAM Leaders Ltd (ASX: WLE) which looks at the larger businesses on the ASX, which you could call the ASX blue-chip shares.

WAM says WAM Leaders actively invests in the highest quality Australian companies.

The WAM Leaders portfolio has delivered gross returns (that’s before fees, expenses, and taxes) of 14.9% per annum since its inception in May 2016. That is superior to the S&P/ASX 200 Accumulation Index average return of 9.8%.

These are the blue-chip ASX shares that WAM outlined in its most recent monthly update:

Fortescue Metals Group Limited (ASX: FMG)

Fortescue Metals is one of the biggest mining businesses in Australia, and the world.

WAM Leaders pointed out that Fortescue Metals has underperformed the market “significantly” over the last six months due to declining iron ore prices.

Chinese authorities have been cutting emissions ahead of next year’s Winter Olympics and reduced demand amid a slowdown in China’s property sector.

However, during November, iron ore prices jumped on the news of stronger than expected economic data from China, according to the fund manager. There was also speculation that China’s steel mills are preparing for an easing of production cuts as early as December, which could help the blue chip ASX share.

WAM Leaders initially invested in Fortescue Metals Group because WAM believes the market’s negative sentiment has far exceeded the reality of the situation in China and continue to hold the company as it offers an attractive double digit free cash flow yield, with further upside potential for the Fortescue share price from the current level.

Crown Resorts Ltd (ASX: CWN)

Crown Resorts was the other business that WAM Leaders picked from its portfolio to outline.

During November 2021, it was revealed that the large gaming and entertainment group had received an acquisition proposal from the US private equity group Blackstone to buy the whole business at an increased price of $12.50 per share.

This bid is the third one from Blackstone for Crown, following previous proposals of $11.85 in March 2021 and $12.35 in May 2021.

WAM said that Crown Resorts was added to the WAM Leaders portfolio because of the significant leverage to the reopening of the borders, the blue chip ASX share’s “high quality” portfolio of assets, the underlying value of its land portfolio and the material steps that Crown Resorts has taken in its reform journey.

The fund manager also thinks there is potential for further takeover interest from Star Entertainment Group Ltd (ASX: SGR) due to the benefits of the potential combined entity including synergies, property scale and unlocking the Sydney market.

The post Leading fund manager says these blue-chip ASX shares are buys right now appeared first on The Motley Fool Australia.

More reading

• Zip (ASX:Z1P) shares just topped these end-of-year rankings
• This broker is bearish on the Fortescue (ASX:FMG) share price
• Crown Resorts share price (ASX:CWN) lifts ahead of culture reform
• What’s boosting the BHP (ASX:BHP) share price 2% higher today?
• Search for new Fortescue (ASX:FMG) boss focused on green ‘transformation’: Twiggy

Motley Fool contributor Tristan Harrison owns Fortescue Metals Group Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3IKwCZh

The MA Financial Group Ltd (ASX: MAF) share price is frozen today after the company requested a trading halt.

Before the freeze, the MA Financial Group share price was trading at $8.45 apiece.

Let’s take a look at what the company announced today.

Why is the share price on ice?

MA Financial Group has been granted a trading halt pending a company announcement.

The update is expected to be noteable, with the company indicating it could involve a significant acquisition.

The Australian Financial Review reported MA Financial Group is in talks to takeover Finsure, which is owned by BNK Banking Corp Ltd (ASX: BBC).

BNK Banking Corp also went into a trading halt on Tuesday pending an announcement.

What is happening at MA Financial?

MA Financial has a significant market capitalisation of more than $1.3 billion.

The company, formerly known as Moelis Australia, offers corporate advisory, equity, and asset management solutions to clients.

In October, the company predicted its FY21 underlying earnings per share (EPS) will increase by 30 to 40% on the previous year.

The company has also recently acquired an iconic Adelaide city office building in partnership with Centuria Capital Limited (ASX: CNI).

MA Financial share price snap shot

In the last 12 months, the MA Financial share price has soared 68%, rallying 78% in the year to date.

Despite this, it’s slipped 3.54% in the last month but gained 0.84% in the past week.

For perspective, the benchmark S&P/ASX 200 Index (ASX: XJO) has returned nearly 11% in the past year.

The post MA Financial (ASX: MAF) share price halted amid ‘significant acquisition’ appeared first on The Motley Fool Australia.

More reading

• Why has the PointsBet (ASX:PBH) share price tumbled 16.5% in a month?
• Leading fund manager says these blue-chip ASX shares are buys right now
• Leading brokers name 3 ASX shares to sell today
• Could inflation cause more volatility than COVID for ASX shares in 2022?
• Here are the 3 most heavily traded ASX 200 shares on Tuesday

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3DQZqM4

Yesterday we looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:

DEXUS Property Group (ASX: DXS)

According to a note out of Citi, its analysts have retained their sell rating and $9.54 price target on this property company’s shares. The broker notes that a number of the company’s peers have recently announced strong updates. While this is likely to bode well for Dexus’ own performance, Citi isn’t in a rush to change its rating. The broker has previously flagged potential for further weakness in office rental markets, which it feels is likely to feed into office asset pricing. The Dexus share price is trading at $11.44 this afternoon.

Insurance Australia Group Ltd (ASX: IAG)

A note out of UBS reveals that its analysts have downgraded this insurance giant’s shares to a sell rating and cut the price target on them to $4.20. UBS is feeling bearish on the company’s outlook, particularly given its lack of growth opportunities. In addition, the broker expects IAG to be impacted by a spike in claims. The IAG share price is fetching $4.36 on Tuesday.

Pact Group Holdings Ltd (ASX: PGH)

Analysts at Morgan Stanley have retained their underweight rating on this packaging company’s shares and cut the price target on them to $2.70. According to the note, Pact is the broker’s least preferred option in the space due to partly to its struggling Contract Manufacturing segment. It expects this business to weigh on its performance and has downgraded its earnings forecasts to reflect this. The Pact share price is trading at $2.44 today.

The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.

More reading

• Why Audinate, Firefinch, IAG, and Ramsay shares are falling
• Broker says sell: IAG (ASX:IAG) share price slumps 3.5%
• ASX 200 (ASX:XJO) midday update: CSL acquisition talks, Charter Hall guidance upgrade
• Top brokers name 3 ASX shares to sell next week
• Why the IAG (ASX:IAG) share price could be cheap for patient investors

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended Insurance Australia Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3GELk22

Volatility is a measure of the ferocity of the market’s changes — violent fluctuations mean high volatility. Much like frantically shaking a fruit tree at its trunk until it relinquishes its ripened goods, investors can be shaken loose of their ASX shares during times of market volatility.

Uncertainty created by COVID-19 has yet to subside, but there are new potential causes of volatility that could unseat COVID.

Will inflation put a dent in ASX shares next year?

As we move towards the end of another year, investors begin to shift their sights to what lies ahead. For AXA Investment Managers chief investment officer Chris Iggo, it marks the realisation there might be other market disruptions than just COVID for the S&P/ASX 200 Index (ASX: XJO) and its constituents.

According to Iggo, the unknowns associated with COVID-19 will likely still linger as a worry for investors. However, the elephant in the room of financial markets is expected to be inflation.

After policymakers around the world looked to contain the economic damage of the pandemic through stimulus and loose monetary policy, the repercussion could manifest itself in the form of higher than expected inflation. Central banks would need to steer the economy in the other direction by potentially raising interest rates.

On this topic, Chris Iggo outlined what scenario investors might be confronted with in 2022:

Looking to 2022, investors need to contemplate a number of issues over the likely trajectory of inflation, whether central banks will need to do more than what is already priced in, and how portfolios should be adapted to hedge against a worse outcome. That worse outcome would be even higher inflation, a more aggressive tightening of monetary policies and a subsequent downgrade to growth prospects.

For Iggo, the risk lies in the Federal Reserve conceding its terminal policy rate to be higher than 2.5%. This would likely boost long-term bond yields substantially higher. In turn, growth investments such as ASX shares would look less attractive.

The verdict

While the risk exists, Iggo and the team at AXA Investment Managers are doubtful of a catastrophe for ASX shares. The fund manager expects a slight increase in rates, in conjunction with a ‘little’ easing in earnings growth. All in all, the fund’s outlook is described as “hardly the stuff of bear markets“.

There are still tailwinds Iggo references that could counter the possible headwinds ahead in 2022.

Iggo said:

Ongoing recovery, innovation around climate change and re-purposing supply chains should be strong tailwinds for equity investors for some time.

So far this year the benchmark index has gained 10.5% before dividends. This surpasses the average total return of 9.3% over the past 10 years.

The post Could inflation cause more volatility than COVID for ASX shares in 2022? appeared first on The Motley Fool Australia.

More reading

• Here are the 3 most heavily traded ASX 200 shares on Tuesday
• What ASX 200 energy shareholders should know about the Permian Basin 2022
• Why is the Wesfarmers (ASX:WES) share price having a day to forget?
• Here’s why the Latrobe Magnesium (ASX:LMG) share price is tumbling 7% today
• Rhythm Biosciences (ASX:RHY) share price roars 8% on new cancer markets

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3dOwFF3

The post Here are the 3 most heavily traded ASX 200 shares on Tuesday appeared first on The Motley Fool Australia.

More reading

• What to look for when investing in ASX microcap shares
• ASX 200 (ASX:XJO) midday update: Afterpay takeover vote, Woolworths crashes
• Could 2022 be a good year for the Vanguard International Shares ETF (ASX:VGS)?
• Here’s why the Charter Hall (ASX:CHC) share price is leaping another 5% today
• 5 things to watch on the ASX 200 on Tuesday

Motley Fool contributor Sebastian Bowen owns Telstra Corporation Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended Telstra Corporation Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/31OsgQj

The S&P/ASX 200 Index (ASX: XJO) has managed to claw back its 0.5% morning loss and is currently up 0.15% in afternoon trade.

The same can’t be said for ASX 200 energy shares today.

The Woodside Petroleum Ltd (ASX: WPL) share price is down 0.22% to $22.23 per share.

Santos Ltd (ASX: STO) is taking a bigger hit, with shares down 0.91% to $6.54 per share.

As for the Oil Search share price? I’d quote it if I could. But Oil Search stopped trading on the ASX on Friday, following its official merger with Santos.

Santos and Woodside are facing some modest headwinds today with crude oil prices slipping overnight. International benchmark Brent Crude is down 0.5% over the past 24 hours, trading at US$74.02 per barrel.

That’s well up from the US$51.80 per barrel Brent was fetching on 1 January. But it’s well down from the US$85.99 that same barrel was worth on 29 October.

ASX 200 energy shares slip alongside oil price

With Brent crude down 14% since 29 October, it’s no surprise that the Woodside share price is also down. Though only by 6.3% since then. Over that same time, the Santos share price has lost 8.2%.

Which brings us back to the expansion plans underway for the Permian Basin.

What’s happening at the Permian Basin?

Most ASX 200 energy shareholders will be at least passingly familiar with the Permian Basin.

Covering more than 200,000 square kilometres, spread across the US states of Texas and New Mexico, the region contains rich oil and gas deposits. With new technologies opening up profitable shale oil extraction over the past decade, the potential output from the Permian Basin has soared.

In fact, as Bloomberg notes, “Crude production from the Permian exceeds that of each OPEC member except Saudi Arabia.”

And that’s just the Permian, mind you. Not the rest of the crude oil potential housed within continental US, Alaska, and offshore.

Why does this matter for ASX 200 energy shareholders in 2022?

Word has it that US shale oil producers are planning to up their output in the Permian.

Rystad energy forecasts that shale oil producers will ramp up their capex by some 20% to US$83.4 billion next year.

According to Bloomberg, Chevron is going to increase its spend in the Permian to $3 billion in 2022. That’s 50% more than the energy giant spent this year.

And the US Energy Information Administration (EIA) forecasts that crude output from the Basin will top 5 million barrels per day (bpd) in January 2022, exceeding pre-pandemic production records.

On the more bullish outlook for ASX 200 energy shares, OPEC+ appears intent to stick to its gradual production increases. And even with the expanded forecast output from the Permian Basin, total crude production in the US in 2022 is still expected to be below its pre-pandemic levels.

The post What ASX 200 energy shareholders should know about the Permian Basin 2022 appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• Could 2022 be a bumper year for the Woodside (ASX:WPL) share price?
• Leading brokers name 3 ASX shares to buy today
• $22 billion of newly merged Santos shares are fronting the ASX this morning. Here’s what you need to know
• 4 ASX shares tipped for buybacks in 2022: expert

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3oSBOlT

Sure, the S&P/ASX 200 Index (ASX: XJO) is not having a great day thus far this Tuesday. At the time of writing, the ASX 200 remains down by around 0.06%, after dipping by almost 0.5% earlier this morning. But why is the Wesfarmers Ltd (ASX: WES) share price doing so much worse?

Wesfarmers shares are currently down by a nasty 2.16% at $58.50 each. They dipped as low as $58.13 earlier in today’s trading session too. So why is Wesfarmers, arguably one of the ASX’s most respected blue-chip shares, in the doldrums today?

Well, unfortunately, we can’t say for sure. There are no major news or announcements out of the company today, or this week for that matter. Or any other relevant direct developments.

Why are Wesfarmers shares in the doldrums today?

However, there is one possible explanation. Wesfarmers’ peer Woolworths Group Ltd (ASX: WOW) is having a shocker today. Woolies released a trading update this morning covering the company’s performance over the first half of FY2022. As my Fool colleague James covered this morning, this update saw Woolworths report Australian Food sales growth of 3% for the half against the same half of FY2021. Woolworths’ Big W chain saw its sales fall by 3.3% over the same period.

Woolworths CEO Bradford Banducci called the results “one of the most challenging halves we have experienced in recent memory”. Clearly, investors agree, seeing they have sent the Woolworths share price down a nasty 8% today so far. It’s presently sitting at $37.31 after closing at $40.72 a share yesterday.

Seeing as Woolworths and Wesfarmers operate in similar (and sometimes overlapping) arenas of the Australian retail market, it’s possible that the fallout from Woolworths’ report this morning has extended to its peers like Wesfarmers. That might also explain why the Coles Group Ltd (ASX: COL) share price is also nursing heavy losses today. It’s currently down 3.2% at $17.30 a share.

So perhaps investors can blame Woolworths for the Wesfarmers share price woes we see today.

At the current Wesfarmers share price, this ASX 200 blue chip has a market capitalisation of $66.06 billion, with a dividend yield of 3.06%. Despite today’s losses, Wesfarmers shares remain up 13.1% year to date in 2021 so far.

The post Why is the Wesfarmers (ASX:WES) share price having a day to forget? appeared first on The Motley Fool Australia.

More reading

• ASX 200 (ASX:XJO) midday update: Afterpay takeover vote, Woolworths crashes
• Why is the Coles (ASX:COL) share price sinking 4% today?
• ASX shares that could be impacted by AdBlue shortage
• Woolworths (ASX:WOW) share price sinks 7% amid ‘one of the most challenging halves’
• Could this tasty morsel be next on the acquisition menu for Woolworths (ASX:WOW)?

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended COLESGROUP DEF SET and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3IMZX5j

The Latrobe Magnesium Limited (ASX: LMG) share price is in the red today following a loan facility announcement.

Shares in the magnesium company fell as low as 9.6 cents today after opening at 11 cents. At the time of writing, they’ve clawed back some ground to 9.9 cents, down 5.71%

The company is developing a magnesium production plant with a patented extraction process in the Latrobe Valley, Victoria.

What did Latrobe announce today?

Latrobe has signed off on a $23 million loan to construct the magnesium production plant. The total cost of the build is $39 million.

The company revealed it now has the funds available to completely pay for the construction of the plant.

Interest on the company’s loan will be charged at 14% per annum up to October 2023 before increasing to 16% to December 2024, with a final capped rate of 24% from January 2025. The term of the loan is five years.

Latrobe hopes to showcase how its hydromet technology can extract high-quality magnesium and other by-products.

The company intends to conduct a pre-feasibility study during 2022 using ferro nickel slag feedstock.

As reported by Motley Fool Australia, the Latrobe share price surged in early trade yesterday after the company secured a property with several buildings to house the production plant.

The deal, worth $4.5 million, will include a combination of a $2.25 million cash payment and the issue of shares to the property’s former owner, the Di Fabrizzio family.

Latrobe share price snapshot

The Latrobe Magnesium share price has gained more than 438% in the past 12 months, rallying 321% this year to date.

Although the company’s shares dived 39% in the last month of trading, they’ve gained 26% this past week.

The company has a market capitalisation of about $151 million, based on the current share price.

The post Here’s why the Latrobe Magnesium (ASX:LMG) share price tumbled 7% today appeared first on The Motley Fool Australia.

More reading

• What’s happening to the Latrobe Magnesium (ASX:LMG) share price today?
• Here’s why the Latrobe Magnesium (ASX:LMG) share price is sinking 7% today
• Why is the Latrobe Magnesium (ASX:LMG) share price down again today?

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3m1Hx77

The Rhythm Biosciences Ltd (ASX: RHY) share price is on the move today. This comes after the company revealed its intentions to expand ColoSTAT into new cancer markets.

At the time of writing, the medical device company’s shares are trading for $1.75 cents, up 4.79%.

What’s driving the Rhythm share price higher?

Investors are fighting to get a hold of Rhythm shares after digesting the company’s encouraging announcement.

According to the release, Rhythm advised that it has identified five new cancer detection markets to expand its platform technology.

As such, ColoSTAT is believed to hold multi-cancer detection properties, which could provide a foundation to expand the platform. Cancer markets include breast, cervical, lung, gastric, and pancreatic.

Rhythm’s ColoSTAT is an experimental test kit that is being trialled as a low-cost, easy-to-use blood test to detect colorectal cancer.

It is estimated that around 850,000 people lose their life from colorectal cancer each year. In the United States, Europe, and Australia, over 130 million people aged between 50-74 years are unscreened for colorectal cancer. This represents an addressable market opportunity of more than $6.5 billion.

The strategic plan to expand the technological platform will form part of a research and development program. This is expected to follow a similar commercial pathway as to ColoSTAT.

The program will have access to $0.75 million worth of funds sourced from the company’s last capital raising. In addition, the program could be eligible for the government R&D tax incentive rebate as well as other grants.

Rhythm CEO and managing director, Glenn Gilbert commented:

As we move closer to the launch of our initial cancer detection product ColoSTAT in 2022, the Company is making positive progress with respect to its broader strategy to leverage our cancer detection technology into other global cancer markets. Ultimately, Rhythm believes it can make a meaningful impact for improved health outcomes across millions of people around the world.

More on the Rhythm share price

The Rhythm share price has accelerated by 110% in the past 12 months, reflecting positive investor sentiment. Additionally, the company’s shares reached an all-time high of $2.08 last month, before treading slightly lower.

At today’s prices, Rhythm presides a market capitalisation of roughly $365.54 million, with approximately 208.88 million shares on issue.

The post Rhythm Biosciences (ASX:RHY) share price roars 8% on new cancer markets appeared first on The Motley Fool Australia.

More reading

• Rhythm Biosciences (ASX: RHY) share price slumps amid ‘pivotal’ board changes
• Rhythm Biosciences (ASX:RHY) share price rockets amid US$12bn market opportunity

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3IFICuW